题名 | First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial |
链接 | https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(21)00797-2.pdf |
谢谢!
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |